Influence of Tightly Glucose Control on Hyperglycemic Toxicity and Protein Catabolism in Critically Ill Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Critically Ill Patients
Interventions
OTHER

Tightly glucose control

A continuous insulin infusion (50 IU of Actrapid HM) in 49.5 ml of 0.9 percent sodium chloride with the use of a pump was started when blood glucose level exceeded 140 mg/dl to maintain a blood glucose level of between 120 and 140 mg per deciliter. The dose of insulin was adjusted according to whole-blood glucose levels, measured at one-four-hour interval in arterial blood or arterial catheter was not available. The insulin dose was adjusted by a neuro-fuzzy method

OTHER

Conventional glucose control

a continuous insulin infusion was delivered when the blood glucose level exceeded 200 mg/dl and insulin level was then adjusted to maintain a blood glucose level of between 180 and 200 mg per deciliter.

Trial Locations (1)

813

Kaohsiung Veterans General Hospital, Kaohsiung City

All Listed Sponsors
lead

Kaohsiung Veterans General Hospital.

OTHER

NCT01227148 - Influence of Tightly Glucose Control on Hyperglycemic Toxicity and Protein Catabolism in Critically Ill Patients | Biotech Hunter | Biotech Hunter